Você procurou por: crestor (Grego - Inglês)

crestor
oral use

crestor 10υοτ ή
film coated tablet

rosuvastatin (crestor) 10 mg
in conclusion, the benefit/ risk ratio is favourable for crestor 5 or crestor 10 mg as alternative start doses.

ανορχότυατ νυονάβµαλ υοπ αµοτά crestor
musculoskeletal, connective tissue and bone disorders common: myalgia rare: myopathy and rhabdomyolysis

οτ ότυα ογόλ οτ αιΓ αίµιαλορετσηλοχρεπυ crestor,
- previous history of muscular toxicity with another hmg-coa reductase inhibitor or fibrate

ςησάφ ςητέλεµ αίεχιοτσ άκιτωρτνεκγυσ όπΑ crestor iii
date of first authorisation/ renewal of the authorisation

υοτ ησήρχ Η αιεκράπενα ήκιρφεν αιρτέµ εµ crestor
if ck levels are significantly elevated at baseline (> 5xuln) a confirmatory test should be carried out within 5 – 7 days.

εµ ςατητόµισηνθ ιακ ςατητόρησον ςετέλεµ ιο ύοφα νωίδιπιλ crestor
in a study in subjects with varying degrees of renal impairment, mild to moderate renal disease had no influence on plasma concentration of rosuvastatin or the n-desmethyl metabolite.

οτ νώνεθσα όµθιρα ονέµσιροιρεπ εµ ςετέλεµ ςέκινιλκ εΣ crestor,
however, two subjects with child-pugh scores of 8 and 9 showed an increase in systemic exposure of at least 2-fold compared to subjects with lower child-pugh scores.

ςιεσόδ εσ ςυοτ ήσιρκόπατνα νητ αιγ νακηθήγολοιξα crestor 20 - 40 mg.
preclinical data reveal no special hazard for humans based on conventional studies of safety pharmacology, repeated dose toxicity, genotoxicity and carcinogenicity potential.

, αίεπαρεθ ναβαλέ υοπ ςίενεθσα εΣ ςεύµ ςύοκιτελεκσ ςυοτσ ςιεσάρδιπΕ crestor οσόν ήκιρφεν
13 rosuvastatin increases the number of hepatic ldl receptors on the cell-surface, enhancing uptake and catabolism of ldl and it inhibits the hepatic synthesis of vldl, thereby reducing the total number of vldl and ldl particles.

crestor, υοτ νώσανιµασναρτ νωτ ςιεσήξυα εΣ ςαίεπαρεθ ςητ ηξρανέ νητ άτεµ ςενήµ ςυοτσ ιακ ςαίεπαρεθ
concomitant use of crestor and an oral contraceptive resulted in an increase in ethinyl oestradiol and norgestrel auc of 26% and 34%, respectively.

εµ αίεπαρεθ ναβαλέ υοπ ςίενεθσα εσ ησυλόυµοδβαρ crestor ςεύµ ςύοκιτελεκσ ςυοτσ ςιεσάρδιπε ίεθρεφανα νυοχΈ,.. ςυµ ςύοκιτελεκσ ςυοτσ ςιεσάρδιπΕ ησόδ νυονάβµαλ υοπ νώνεθσα νωτ νωχγέλε 40 mg.
however, an increase in the incidence of myositis and myopathy has been seen in patients receiving other hmg-coa reductase inhibitors together with fibric acid derivatives including gemfibrozil, cyclosporin, nicotinic acid, azole antifungals, protease inhibitors and macrolide antibiotics.

crestor 10υοτ ή crestor 5 mgυοτ ήγολιπε νητ ίεγολοιακιδ υονύδνικ ςαιελέφω ησέχσ η ιτό ιατεγάνυΣ / 8 ΣΟΤΝΟΪΟΡΠ ΥΟΤ ΝΩΚΙΤΣΙΡΗΤΚΑΡΑΧ ΝΩΤ ΗΨΗΛΙΡΕΠ iiΙ ΑΜΗΤΡΑΡΑΠ 9 ήφορτ ςίρωχ ή εµ ςαρέµη ςητ αρώ ετοπήδαιοπο ιατενάβµαλ αν ίεροπµ
the choice of start dose in the individual patient should take into account aspects of efficacy and safety, as detailed in the spc.

ητ αιγ ςαίροφολκυκ αιεδά ίεθηρωχαραπ ιεχέ νώλεµ νώταρκ νωτ ατητόνοιελπ νητσ ςοτνόραπ υοτ αµητράραπ επέλβ ΝΩΙΣΑΜΟΝΟ ΝΩΦΑΝΥΣ ΝΩΤ ΙΑΚ i) (crestor 5 mg ΥΟΤ ΣΗΣΗΓΟΛΟΙΞΑ ΣΗΚΙΝΟΜΗΤΣΙΠΕ ΣΗΤ ΗΨΗΛΙΡΕΠ ΗΚΙΝΕΓ 7
the choice of start dose in the individual patient should take into account aspects of efficacy and safety, as detailed in the spc.